Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Bio-Works Technologies AB (publ) (BIOWKS.ST)

Stockholm - Stockholm Real Time Price. Currency in SEK
Add to watchlist
22.50-0.10 (-0.44%)
At close: 5:29PM CEST
Advertisement

Bio-Works Technologies AB (publ)

Virdings allé 18
Uppsala 75450
Sweden
46 8 56 26 74 30
http://www.bio-works.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees31

Key Executives

NameTitlePayExercisedYear Born
Mr. Jonathan RoyceChief Exec. OfficerN/AN/AN/A
Mr. Jan BerglöfCo-Founder & Sr. AdvisorN/AN/AN/A
Mr. Tord KallioniemiChief Financial OfficerN/AN/AN/A
Mr. Karsten FjärstedtChief Operating OfficerN/AN/AN/A
Ms. Line ThomsonPeople & CultureN/AN/AN/A
Ms. Helena PahlmSr. Director of Global QualityN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.

Description

Bio-Works Technologies AB (publ) researches, develops, manufactures, and supplies agarose based resins used to separate proteins and other biomolecules. It offers activated and affinity resins; BabyBio columns; immobilized metal-ion affinity chromatography (IMAC) resins; ion exchange resins; OptioBio glass columns; and size exclusion chromatography (SEC) resins. The company's products are used in antibody, His-tagged proteins, proteins, peptides, oligonucleotides, and viruses and vaccines purification process. Bio-Works Technologies AB (publ) founded in 2006 and is based in Uppsala, Sweden.

Corporate Governance

Bio-Works Technologies AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement